Terrence N Wong, MD PhD

Affiliations: 
2012-2019 Medicine Washington University, Saint Louis, St. Louis, MO 
Google:
"Terrence Wong"

Parents

Sign in to add mentor
David M. Lemal research assistant 1999-2001 Dartmouth (Chemistry Tree)
Tao Pan grad student 2003-2007 Chicago (Chemistry Tree)
Daniel C. Link post-doc 2012-2019 Washington University
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Chen S, Wang Q, Yu H, et al. (2020) Author Correction: Mutant p53 drives clonal hematopoiesis through modulating epigenetic pathway. Nature Communications. 11: 3856
Chen S, Wang Q, Yu H, et al. (2019) Mutant p53 drives clonal hematopoiesis through modulating epigenetic pathway. Nature Communications. 10: 5649
Berrien-Elliott MM, Sun Y, Neal C, et al. (2019) MicroRNA-142 Is Critical for the Homeostasis and Function of Type 1 Innate Lymphoid Cells. Immunity
Trissal MC, Wong TN, Yao JC, et al. (2018) MIR142 loss-of-function mutations derepress ASH1L to increase HOXA gene expression and promote leukemogenesis. Cancer Research
Wong TN, Miller CA, Jotte MRM, et al. (2018) Cellular stressors contribute to the expansion of hematopoietic clones of varying leukemic potential. Nature Communications. 9: 455
Wong TN, Link DC. (2017) miR-125b promotes leukemogenesis via VEGFA. Blood. 129: 1409-1410
Wong TN, Miller CA, Jotte MR, et al. (2017) Cellular Stressors Contribute to the Expansion of Multiple Hematopoietic Clones of Varying Leukemic Potential Blood. 130: 469-469
Yao J, Wong TN, Trissal M, et al. (2017) Abstract 3042:MIR142loss-of-function mutations promote leukemogenesis through derepression ofASH1Lresulting in increasedHOXgene expression Cancer Research. 77: 3042-3042
Yao J, Wong TN, Trissal M, et al. (2016) MIR142 Loss-of-Function Mutations Promote Leukemogenesis through Derepression of ASH1L Resulting in Increased HOX Gene Expression Blood. 128: 2718-2718
Wong TN, Miller CA, Klco JM, et al. (2015) Rapid expansion of pre-existing non-leukemic hematopoietic clones frequently follows induction therapy for de novo AML. Blood
See more...